Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
Barete, Stéphane
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis. [electronic resource] - Blood Aug 2015 - 1009-16; quiz 1050 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2014-12-614743 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Cladribine--therapeutic use
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Mastocytosis--drug therapy
Middle Aged
Retrospective Studies
Treatment Outcome
Young Adult
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis. [electronic resource] - Blood Aug 2015 - 1009-16; quiz 1050 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2014-12-614743 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Cladribine--therapeutic use
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Mastocytosis--drug therapy
Middle Aged
Retrospective Studies
Treatment Outcome
Young Adult